Loading...
Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
BACKGROUND: Guidelines recommend that treatment with a long-acting β(2) agonist (LABA), a long-acting muscarinic antagonist (LAMA), and inhaled corticosteroids (ICS), i.e. triple therapy, is reserved for a select group of symptomatic patients with chronic obstructive pulmonary disease (COPD) who con...
Na minha lista:
| Udgivet i: | Respir Res |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6829989/ https://ncbi.nlm.nih.gov/pubmed/31684965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1213-9 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|